Basilea Pharmaceutica AG Profit Margin

As of the most recent data (June 2026), BPMUF shows a profit margin of 27.13%. That compares with 17.19% in the prior-year period — up 57.8% year over year. That is above the Healthcare sector average of 10.58%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BPMUF's profit margin is now 27.13% (was 17.19%) — a 57.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Basilea Pharmaceutica AG is outperforming or lagging.

The Healthcare sector average profit margin is about 10.58%. Basilea Pharmaceutica AG is at 27.13%, which is higher that average. That is roughly 156.4% above the sector mean. Use the comparison chart on this page to see how BPMUF stacks up against individual peers as well.

That compares with 17.19% in the prior-year period — up 57.8% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Basilea Pharmaceutica AG with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Basilea Pharmaceutica AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 27.13%) with ownership activity and broader fundamentals.